Hemfosa’s rights issue fully subscribed
The result of Hemfosa Fastigheter AB’s (publ) (“Hemfosa”) rights issue, for which the subscription period ended on May 10, 2016, indicates that 26,189,261 ordinary shares, representing approximately 99.6 percent of the offered ordinary shares, were subscribed for by the exercise of subscription rights. Additionally, applications for subscription without subscription rights corresponding to 12,836,102 ordinary shares, corresponding to approximately 48.8 percent of the offered ordinary shares, have been received. Thus, the rights issue is fully subscribed. Through the rights issue, Hemfosa will receive proceeds amounting to approximately MSEK 1,814 before transaction costs.
‒ The rights issue represents a powerful move by Hemfosa and we are pleased that the response has been so positive. Our clear ambition is to continue growing and we see many attractive business opportunities in our three geographical markets. We have now created greater scope for acquisitions, which will allow us to continue to establish Hemfosa as a recognized and powerful player in community service properties,” says Jens Engwall, CEO of Hemfosa Fastigheter.
Those who have subscribed for ordinary shares without subscription rights will be allotted shares according to the principles outlined in the prospectus. Such subscribers who have been allotted shares without subscription rights are expected to be notified on May 16, 2016. Only those who are allotted ordinary shares will be notified.
Through the rights issue Hemfosa’s share capital increases by SEK 13,144,020.50 from SEK 71,220,103.50 to SEK 84,364,124 and the total number of ordinary shares increases by 26,288,041 from 131,440,208 to 157,728,249 when the rights issue is registered at the Swedish Companies Registration Office.
The final day for trading in paid subscribed shares (BTAs) is expected to be May 19, 2016. The new ordinary shares subscribed for with subscription rights are expected to start trading on Nasdaq Stockholm on May 23, 2016, and the shares subscribed for without subscription rights on May 25, 2016.
Financial and legal advisors
SEB Corporate Finance and Swedbank Corporate Finance are acting as financial advisors and Advokatfirman Cederquist as legal advisor to Hemfosa in connection to the rights issue.
Nacka May 13, 2016
Hemfosa Fastigheter AB (publ)
The Board of Directors
This press release does not contain or constitute an invitation or an offer to acquire, sell, subscribe for or otherwise trade in shares, subscription rights or other securities in Hemfosa. Invitation to the persons concerned to subscribe for shares in Hemfosa was only be made through the prospectus that has been approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and which has been published at Hemfosa's website. The prospectus contains, among other things, risk factors, financial statements as well as information regarding Hemfosa's Board of Directors. This press release has not been approved by any regulatory authority and is not a prospectus.
In certain jurisdictions, the publication or distribution of this press release may be subject to restrictions according to law and persons in those jurisdictions where this press release has been published or distributed should inform themselves about and abide by such restrictions.
This press release is not directed at persons located in the United States (including its territories and possessions, any state of the United States and the District of Columbia), Canada, Australia, Hong Kong, Japan, New Zealand, Singapore, South Africa or in any other country where the offer or sale of the subscription rights, paid subscribed shares (Sw. betalda tecknade aktier) or new shares is not permitted. This press release may not be announced, published or distributed, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or any other country where such action is wholly or partially subject to legal restrictions or where such action would require additional prospectuses, other offer documentation, registrations or other actions in addition to what follows from Swedish law. Nor may the information in this press release be forwarded, reproduced or disclosed in such a manner that contravenes such restrictions or would require such additional prospectuses, other offer documentation, registrations or other actions. Failure to comply with this instruction may result in a violation of the United States Securities Act of 1933, as amended (the "Securities Act") or laws applicable in other jurisdictions.
In addition, if and to the extent that this press release is communicated in any European Economic Area member state that has implemented Directive 2003/71/EC (together with any applicable implementing measures, including Directive 2010/73/EC, in any member state, the "Prospectus Directive"), this press release is only addressed to and directed at persons in that member state who are "qualified investors" within the meaning of the Prospectus Directive and must not be acted on or relied on by other persons in that member state. This press release does not constitute a prospectus within the meaning of the Prospectus Directive or an offer to the public.
In the United Kingdom, this press release is being distributed only to, and is directed only at (i) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Financial Promotion Order"), (ii) persons falling within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Promotion Order, or (iii) other persons to whom it may otherwise be lawfully communicated (all such persons together being referred to as "relevant persons"). This press release is directed only at relevant persons and must not be acted on or relied on by anyone who is not a relevant person.
No subscription rights, paid subscribed shares or new shares have been or will be registered under the Securities Act, or with any other securities regulatory authority of any state or other jurisdiction of the United States and no subscription rights, paid subscribed shares or new shares may be offered, sold, resold, transferred, delivered or distributed, directly or indirectly, into or within the United States or on account of such persons other than pursuant to an exemption from, or in a transaction not subject to the registration requirements of the Securities Act, and in compliance with any applicable securities laws of any state or jurisdiction of the United States. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States.
For more information, please contact:
Bengt Kjell, Chairman of the Board, Tel: +46 705 94 5398
Jens Engwall, CEO, firstname.lastname@example.org, Tel: +46 706 90 6550, Office: +46 8 448 04 80
Hemfosa AB (publ) discloses the information in this press release according to the Swedish Securities Markets Act and/or the Swedish Financial trading Act. The information was provided for public release on May 13, 2016 at 7.30 a.m.